Company details
About
Atea’s most advanced antiviral drug candidate, AT-527, is being evaluated in a Phase 2 clinical trial in the US for the treatment of patients with moderate COVID-19 and risk factors for poor outcomes
Number of employees
5001 - 10000
Main industry
Information Technology
Industry tags
Headquarters
Oslo
Country
Norway
Sign up to uncover company details
5 free credit every month
Employee contacts
Name
Job Title
Phone
Reach Decision Makers
at Atea
